Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0MS4Z
|
|||
Former ID |
DNC012076
|
|||
Drug Name |
N-(3,3-Dimethyl-butyl)-4-hexyloxy-benzamide
|
|||
Synonyms |
CHEMBL122341; N-(3,3-Dimethyl-butyl)-4-hexyloxy-benzamide; ZINC13864671; BDBM50106166
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C19H31NO2
|
|||
Canonical SMILES |
CCCCCCOC1=CC=C(C=C1)C(=O)NCCC(C)(C)C
|
|||
InChI |
1S/C19H31NO2/c1-5-6-7-8-15-22-17-11-9-16(10-12-17)18(21)20-14-13-19(2,3)4/h9-12H,5-8,13-15H2,1-4H3,(H,20,21)
|
|||
InChIKey |
JPQPUSQXWSSOFH-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Voltage-gated potassium channel Kv7.1 (KCNQ1) | Target Info | Inhibitor | [1] |
KEGG Pathway | Adrenergic signaling in cardiomyocytes | |||
Cholinergic synapse | ||||
Gastric acid secretion | ||||
Pancreatic secretion | ||||
Protein digestion and absorption | ||||
Vibrio cholerae infection | ||||
Pathwhiz Pathway | Muscle/Heart Contraction | |||
Reactome | Voltage gated Potassium channels | |||
WikiPathways | SIDS Susceptibility Pathways | |||
Potassium Channels | ||||
miR-targeted genes in muscle cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase | ||||
TarBasePathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers. J Med Chem. 2001 Nov 8;44(23):3764-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.